0001140361-12-015190.txt : 20120313
0001140361-12-015190.hdr.sgml : 20120313
20120313155532
ACCESSION NUMBER: 0001140361-12-015190
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120307
FILED AS OF DATE: 20120313
DATE AS OF CHANGE: 20120313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wilson Kenneth W.
CENTRAL INDEX KEY: 0001530777
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 12687139
MAIL ADDRESS:
STREET 1: C/O HANGER ORTHOPEDIC GROUP, INC.
STREET 2: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0304
4
2012-03-07
0
0000722723
HANGER ORTHOPEDIC GROUP INC
HGR
0001530777
Wilson Kenneth W.
C/O HANGER ORTHOPEDIC GROUP, INC.
10910 DOMAIN DRIVE, SUITE 300
AUSTIN
TX
78758
0
1
0
0
Pres./COO Southern Prosthetic*
Common Stock
2012-03-07
4
A
0
3000
0
A
18000
D
The restricted stock being reported does not include the contingent right of the reporting person to receive up to 9,000 additional performance shares under the issuer's 2010 Omnibus Incentive Plan based on the achievement of certain performance targets for the fiscal year 2012.
Includes (i) unvested restricted shares which total 3,000 shares of stock from an initial grant of 3,000 shares of restricted stock made on March 7, 2012; and (ii) unvested restricted shares which total 15,000 shares of stock from an initial grant of 15,000 shares of restricted stock made on September 19, 2011. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
* President and Chief Operating Officer of Southern Prosthetic Supply, Inc.
Jessica Lochmann Allen, Attorney-in-Fact for Kenneth W. Wilson
2012-03-13